A Biography Of Peter Briger, Principle of Fortress Investment Group

Peter L Briger, self-made billionaire and co-chair of the prominent wealth management firm Fortress Investment Group has worked hard to get to where he is today. Despite creating his own success, he puts much of his time, money, and energy into philanthropic enterprises.

Where He Came From

Before joining Fortress Investment Group, Peter Briger began his adult life like any other Ivy League coed. With a strong vision for where he wanted to go in life, Briger finished his initial degree at Princeton, before attending the Wharton School of Business and graduating with a hard-won Masters of Business Administration. With his degree fresh in hand, Briger began working at the prestigious Goldman Sachs, where he stayed for 15 years and made partner before turning his attention to the relative newcomer Fortress Investment Group.

Where He’s Going

Peter Briger joined Fortress Investment Group, where his experience as a partner at a prestigious firm landed him an upper-level management position right out of the gate. It wasn’t long before Briger became a principle and joined the board. In February of 2008 Fortress Investment Group entered the open market, turning it’s principles, including Briger, into billionaires. What sets Peter Briger apart is what he has done with his success. Rather than squandering or hoarding his wealth and power, Briger has been giving it to those in need. He is actively involved in the following philanthropies:

  • The Hospital for Special Surgery- A renowned hospital in New York, and other places, that specializes in orthopedic surgery. They offer generous programs to assist the disadvantaged who need their services.
  • Global Fund For Children- This charity focusses its resources on start-ups and initiatives that will benefit the neediest of children worldwide.
  • Tipping Point- A social justice charity with the drive to help the economically disadvantaged citizens of New York.
  • Caliber Schools- These professionals manage a network of charter schools dedicated to helping students succeed in college and beyond.

Peter Briger and Fortress Investment Group look forward to continuing to grow together, to improve their own fortunes, as well as the fortunes of their communities.

Meet Dr. Cameron Clokie the CEO of Canada’s Induce Biologics Inc.

Manipulating bones to grow especially in adults seems like an impossibility, but regenerative medicine is capable of it. The field of medicine which is somewhat controversial is improving every single day, and it could soon be appealing to people who currently hold a different view courtesy of their religious beliefs. Learn more about Cameron Clokie: http://www.ideacity.ca/speaker/cameron-clokie/

For example, one Canadian doctor—Cameron Clokie—is at an advanced stage of scientific research aimed at the sourcing of bone morphogenetic protein (BMP) from an alternative source than cadavers. The protein is at the heart of regenerative medicine. Dr. Clokie’s plans involve nurturing a human gene that produces BMP inside a goat’s body.

As a result, goats will dispense the protein in large quantities through their milk. If Dr. Clokie’s plans materialize, he will be one step ahead of making regenerative medicine widely acceptable.

Who is Dr. Cameron Clokie? He is the go-to professional regarding regenerative medicine. Part of his 30-year career in either in academic dentistry or clinical practice somehow focused on regenerative medicine. Dr. Clokie has authored many peer-reviewed papers touching on regenerative medicine. Read more: Bros Don’t Let Bros Have Bad Breath: Toronto Oral Surgeon Cameron Clokie Helps You Make a Good First Impression

He is frequently invited to conferences both in Canada and abroad to talk about what he is well-versed in, regenerative medicine. Before his retirement earlier in the year, he was a professor at the University of Toronto. He was also the in charge of Oral and Maxillofacial Surgery at the same institution.

Dr. Clokie’s interest in regenerative medicine extends past clinical practice and academics; he is an entrepreneur in the field of medicine.

Besides being a board member or scientific advisor to many companies interested in scientific research, Dr. Clokie has partnered with companies that are willing to commercialize some of his research work. Dr. Clokie’s over 25 patents in the U.S and other parts of the world demonstrates his interest to uncover new helpful findings.

Presently, Dr. Clokie is the president of Induce Biologics Inc. The Canadian based firm has carved a niche for itself as the world’s leading center where innovative solutions for musculoskeletal reconstruction are abundant.

Induce Biologics comprises professionals who match up to Dr. Clokie’s expertise in regenerative medicine. The firm is working round the clock to make regenerative medicine more efficient and acceptable.

Madison Street Capital Announced as Finalist for the 15th Annual M&A Advisor Awards

The M&A Advisor has announced that the Madison Street Capital financial banking institution is among the finals at the 15th Annual M&A Advisor Awards. The awards, respected widely as a pinnacle of achievement in the financial world, recognize their deal-making excellence. They are recognized as leaders in financing and restructuring. These awards celebrate the achievements and contributions of leading professionals and firms.

Madison Street Capital is one of the nominees for the Industrials and International Deal of the year (Under $100 M) and the Boutique Investment Banking Firm of the year. These awards recognize Madison Street Capital’s role in the Acuna & Asociados S.A. acquisition by Dowco. The managing director of Madison Street Capita, Karl D’Cunha, has led the transaction.

Charles Botchway, the CEO and founder of Madison Street Capital, says that they are extremely pleased with their ability to assist their clients in their Acuna & Asociados S.A. acquisition. They are honored and thrilled to run for the Boutique Investment Banking Firm of the year. For continued growth and success, he says that their deal-makers work tirelessly to connect their clients with the emerging and growing businesses to suit their diverse needs.

The acquisition of Acuna Asociados S.A. by Dowco Company was a cross-border transaction that flexed the muscles of Madison Street Capital. For the sake of that achievement, it feels great. The winners of these awards will be announced at the Annual M&A Acquisition Gala Advisor Awards in New York Athletic Club.

Madison Street Capital is one of the biggest investment banks in the United States. It is committed to leadership, integrity, service, and excellence in delivering mergers and acquisition expertise, financial advisory services, valuation services to privately and publicly-held companies. These services position their clients to take advantage of the dynamic global market. The customer’s objectives and goals become Madison Street Capital’s in undertaking their projects. These services range from successful capital raises and financial advisory to M&A acquisitions to ownership transfer. The company views the emerging trends in the market as the components driving the world growth of clients. Madison Street Capital continues to focus on significant market assets. The firm continues to earn client’s trust in the world through their unwavering dedication to professional standards.

For over 15 years, the company has established itself as the focal point regarding the global network of mergers and acquisition. They are also leaders in financial professions and Turnaround. While they remain privileged in presenting, they also recognize connection facilitation and achievements between the top performers in this industry. They know the companies that take the lead in their services. http://www.benzinga.com/pressreleases/16/08/r8401008/madison-street-capital-announced-as-finalist-for-the-15th-annual-m-a-ad